Filter Results:
(5,436)
Show Results For
- All HBS Web
(5,436)
- People (16)
- News (2,045)
- Research (2,750)
- Events (8)
- Multimedia (223)
- Faculty Publications (1,951)
Show Results For
- All HBS Web
(5,436)
- People (16)
- News (2,045)
- Research (2,750)
- Events (8)
- Multimedia (223)
- Faculty Publications (1,951)
- July 1990
- Case
Food Science Corp. (FSC)--Cholesterol Extraction and Other Technology Applied to Health Hazards in the Food Chain
By: Ray A. Goldberg
Goldberg, Ray A. "Food Science Corp. (FSC)--Cholesterol Extraction and Other Technology Applied to Health Hazards in the Food Chain." Harvard Business School Case 591-018, July 1990.
- March 2020
- Case
China's Management of COVID-19 (A): People's War or Chernobyl Moment?
By: Meg Rithmire and Courtney Han
In late 2019, a novel respiratory virus appeared in a province in central China. Government officials in Wuhan, Hubei province had to respond to the new virus in the shadow of the 2002–2003 outbreak of SARS in China and within the context of the country’s public health... View Details
Keywords: COVID-19; Coronavirus; Pandemics; Public Health; COVID-19 Pandemic; Health Pandemics; Government Administration; Social Issues; Policy; Decision Making; China
Rithmire, Meg, and Courtney Han. "China's Management of COVID-19 (A): People's War or Chernobyl Moment?" Harvard Business School Case 720-035, March 2020.
- November 2013 (Revised January 2015)
- Case
Obamacare
By: Matthew Weinzierl and Katrina Flanagan
One vote in June, 2012, decided the fate of President Barack Obama's crowning first-term achievement: universal health insurance. Chief Justice John Roberts of the U.S. Supreme Court cast the deciding vote to uphold the keystone of the reform: the mandate to purchase... View Details
Keywords: Universal Health Insurance; Adverse Selection; Leviathan; Courts and Trials; Judgments; Insurance; Health Care and Treatment; Government and Politics; Health Industry; Health Industry; Health Industry; United States
Weinzierl, Matthew, and Katrina Flanagan. "Obamacare." Harvard Business School Case 714-029, November 2013. (Revised January 2015.)
- October 2002
- Book Review
Book Review of Beatrix Hoffman's The Wages of Sickness: The Politics of Health Insurance in Progressive America
By: David A. Moss
Moss, David A. "Book Review of Beatrix Hoffman's The Wages of Sickness: The Politics of Health Insurance in Progressive America." Journal of Health Politics, Policy and Law 27, no. 5 (October 2002): 869–873.
- Article
The CMS New Rule on Ambulatory Surgical Centers Earns Only Partial Credit
By: Junaid Nabi and Robert S. Kaplan
The Centers of Medicare and Medicaid Services (CMS) recently announced that it will be removing more... View Details
Keywords: Ambulatory Care; Payment Policy; Health Care and Treatment; Governing Rules, Regulations, and Reforms
Nabi, Junaid, and Robert S. Kaplan. "The CMS New Rule on Ambulatory Surgical Centers Earns Only Partial Credit." Health Affairs Blog (June 2, 2021).
Regina E. Herzlinger
Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and serve on many established and start-up corporate health care/medical... View Details
Bohan Li
Bohan is a doctoral student in Health Policy Management. She graduated from the University of Pennsylvania in 2018 with a double major in Chemistry and Economics. Post-graduation, Bohan spent 4 years as a management consultant advising both payers and providers,... View Details
- October 2014 (Revised April 2023)
- Case
Gilead: Hepatitis C Access Strategy (A)
By: V. Kasturi Rangan, Vikram Rangan and David E. Bloom
Gilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the... View Details
Keywords: Healthcare; Pharmaceuticals; Pricing; Access To Care; Emerging Markets; Health Care and Treatment; Price; Strategy; Ethics; Health Industry; Health Industry
Rangan, V. Kasturi, Vikram Rangan, and David E. Bloom. "Gilead: Hepatitis C Access Strategy (A)." Harvard Business School Case 515-025, October 2014. (Revised April 2023.)
- 30 Jan 2018
- News
The erosion of worker compensation
- March 5, 2022
- Article
Hospital Capacity Shortages: An SEC-Backed Transparency “PULL” Will Open Beds Faster Than a “PUSH” by HHS
In the new normal of ongoing pandemics, hospital bed shortages will continue. Healthcare innovation expert and author of the upcoming book Innovating in Healthcare: Creating Breakthrough Services, Products, and Business Models (Wiley, 2023, 978-1119543008), HBS... View Details
Keywords: Hospital Capacity; Access To Care; Health Pandemics; Health Care and Treatment; Performance Capacity; Planning
Herzlinger, Regina E. "Hospital Capacity Shortages: An SEC-Backed Transparency “PULL” Will Open Beds Faster Than a “PUSH” by HHS." Healthcare Business Today (March 5, 2022).
- Article
Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated
By: Christopher Ody, Lucy Msall, Leemore S. Dafny, David Grabowski and David Cutler
Medicare’s Hospital Readmissions Reduction Program (HRRP) has been credited with lowering risk-adjusted readmission rates for targeted conditions at general acute care hospitals. However, these reductions appear to be illusory or overstated. This is because a... View Details
Keywords: Readmission Rates; Hospitals; Acute Care Hospitals; Medicare; Myocardial Infarction; Heart Failure; Health Care and Treatment
Ody, Christopher, Lucy Msall, Leemore S. Dafny, David Grabowski, and David Cutler. "Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated." Health Affairs 38, no. 1 (January 2019): 36–43.
- August 2020
- Case
Sangu Delle
By: Leslie Perlow and Matthew Preble
By 2020, Sangu Delle (MBA 2016) has already made significant progress towards his life-long goal of solving Africa’s myriad and diverse challenges. At 33 years old, he is the founder and chairman of the for-profit Golden Palm Investments Corporation, CEO of Africa... View Details
Keywords: Impact; Impact Investing; Mental Health; Social Capitalism; Entrepreneurship; Investment; Health Care and Treatment; Personal Development and Career; Health Industry; Africa
Perlow, Leslie, and Matthew Preble. "Sangu Delle." Harvard Business School Case 421-031, August 2020.
- September 2020
- Article
Regulatory Sandboxes: A Cure for mHealth Pilotitis?
By: Abhishek Bhatia, Rahul Matthan, Tarun Khanna and Satchit Balsari
Mobile health (mHealth) and related digital health interventions in the past decade have not always scaled globally as anticipated earlier despite large investments by governments and philanthropic foundations. The implementation of digital health tools has suffered... View Details
Keywords: COVID-19; mHealth; Digital Health; Design Thinking; Regulation; Intervention; Regulatory Sandbox; Health Care and Treatment; Technological Innovation; Design; Governing Rules, Regulations, and Reforms; India
Bhatia, Abhishek, Rahul Matthan, Tarun Khanna, and Satchit Balsari. "Regulatory Sandboxes: A Cure for mHealth Pilotitis?" Journal of Medical Internet Research 22, no. 9 (September 2020).
- March 2014 (Revised September 2014)
- Supplement
Cancer Treatment Centers of America® (B)
By: Regina E. Herzlinger and Natalie Kindred
This case, a follow-up to Cancer Treatment Centers of America (A), HBS No. 313-012, begins with the debate over New Hampshire's certificate-of-need (CON) law, which restricts hospital expansion. This debate ignited significant public criticism of Cancer Treatment... View Details
Keywords: Cancer; Cancer Treatment; Accountability; Outcomes; Outcomes Reporting; Outcomes Measurement; Survival; For-profit Hospitals; Health Care; Healthcare; Hospital; Certificate Of Need; Health Care and Treatment; Outcome or Result; Corporate Accountability; Policy; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (B)." Harvard Business School Supplement 314-003, March 2014. (Revised September 2014.)
- July 2014
- Article
Second-Opinion Pathologic Review is a Patient Safety Mechanism That Helps Reduce Error and Decrease Waste
By: Lavinia Middleton, Thomas W. Feeley, Heidi W. Albright, Ronald Walters and Stanley Hamilton
We have a crisis in health care delivery, originating from increasing health care costs and inconsistent quality-of-care measures. During the past several years, value-based health care delivery has gained increasing attention as an approach to control costs and... View Details
Keywords: Pathology; Diagnostic Errors; Health Care and Treatment; Health Industry; North and Central America
Middleton, Lavinia, Thomas W. Feeley, Heidi W. Albright, Ronald Walters, and Stanley Hamilton. "Second-Opinion Pathologic Review is a Patient Safety Mechanism That Helps Reduce Error and Decrease Waste." Journal of Oncology Practice 10, no. 4 (July 2014): 275–280. (e-Pub 4/2014. PMID: 24695900.)
- November 2007 (Revised January 2010)
- Case
ThedaCare: System Strategy
By: Michael E. Porter and Sachin H. Jain
Over the 1980s and 1990s, America's changing health care payer environment resulted in mergers of numerous community hospitals into hospital systems. Based in Appleton, Wisconsin, ThedaCare stood out among community hospital systems in its pursuit of service... View Details
Keywords: Value Creation; Health Care and Treatment; Problems and Challenges; Innovation and Invention; Health Industry; Wisconsin
Porter, Michael E., and Sachin H. Jain. "ThedaCare: System Strategy." Harvard Business School Case 708-424, November 2007. (Revised January 2010.)
- 23 Jun 2023
- HBS Case
This Company Lets Employees Take Charge—Even with Life and Death Decisions
example for companies struggling to re-engage “quiet quitters” while balancing rising costs and mixed economic signals. The company began in the Netherlands in 2006 as an antidote to what the founders viewed as innovation-crushing managed... View Details
- August 2018 (Revised February 2023)
- Case
Hubble Contact Lenses: Data Driven Direct-to-Consumer Marketing
By: Jill Avery and Ayelet Israeli
As its Series A extension round approaches, the founders of Hubble, a subscription-based, social-media fueled, direct-to-consumer (DTC) brand of contact lenses, are reflecting on the marketing strategies that have taken them to a valuation of $200 million and debating... View Details
Keywords: DTC; Direct To Consumer Marketing; Health Care; Mobile; Attribution; Experimentation; Experiments; Churn/retention; Customer Lifetime Value; Internet Marketing; Big Data; Analytics; A/B Testing; CRM; Advertising; Marketing; Marketing Channels; Marketing Strategy; Media; Brands and Branding; Marketing Communications; Digital Marketing; Consumer Behavior; Acquisition; Growth and Development Strategy; Customer Focus and Relationships; Social Media; E-commerce; Analytics and Data Science; Health Industry; Health Industry; United States; North America; Europe
Avery, Jill, and Ayelet Israeli. "Hubble Contact Lenses: Data Driven Direct-to-Consumer Marketing." Harvard Business School Case 519-011, August 2018. (Revised February 2023.)